InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Wednesday, 01/06/2021 8:24:28 PM

Wednesday, January 06, 2021 8:24:28 PM

Post# of 245
Last trade 4.87 shorts are going to get their clocks cleaned. Shorting a Kathy Woods gene editing ARKG ETF stock has to be the stupidest thing one can do. If you sold today you got robbed for your shares.

ARKG ETF Holdings:
https://ark-funds.com/wp-content/fundsiteliterature/holdings/ARK_GENOMIC_REVOLUTION_MULTISECTOR_ETF_ARKG_HOLDINGS.pdf


know what you own.

EVGN website:
https://www.evogene.com/


EVGN Biz Presentation:
https://www.evogene.com/wp-content/uploads/2020/05/Evogene_Investor_PPT_May-2020-file.pdf

REHOVOT, Israel, Jan. 5, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across several market segments, provided today a year-end update for the CRISPR-IL consortium, of which it is a member and Evogene's CSO, Dr. Eyal Emmanuel, serves as the consortium's Chairman. The CRISPR-IL consortium, which is supported by the Israeli Innovation Authority, was established to develop an artificial intelligence-based system, for CRISPR-CAS based workflows, "Go-Genome", providing end-to-end genome-editing, with improved precision and efficiency.
https://www.biospace.com/article/releases/evogene-provides-2020-year-end-update-for-crispr-il-consortium/



Genome Stocks-Gene Editing.
$BEAM 5 billion market cap
$EDIT 5.1 billion market cap
$SGMO 2.3 billion market cap
$NTLA 4.4 billion market cap
$BLUE 3 billion market cap
$BNGO 850 million market cap

$EVGN 180 million market cap 35 million shares 45% owned by institutions & insiders


$EVGN
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVGN News